Literature DB >> 12479665

A clinical monitoring form for mood disorders.

Gary S Sachs1, Constance Guille, Stephanie L McMurrich.   

Abstract

OBJECTIVE: The Clinical Monitoring Form (CMF) for mood disorders was developed as a time efficient record keeping tool for routine clinical use. This report presents preliminary data evaluating the correlation between the CMF's dimensional subscales for depression and mood elevation and formal mood rating scales across a wide spectrum of mood states.
METHODS: To harvest data for 500 follow-up visits required collection of data from consecutive records accumulated during the conduct of seven double blind clinical trials involving a total of 58 participants. These trials utilized the CMF as a source document in conjunction with formal study outcome scales, e.g. Hamilton Rating Scale for Depression (HRSD), the Montgomery-Asberg Depression Rating Scale (MADRS), the Young Mania Rating Scale (YMRS) and the Mania Rating Scale (MRS) from the Schedule of Affective Disorders-Current (SUM-C). Correlation coefficients were calculated to examine the relationship between the formal rating scales, Clinical Global Impression and the depression (SUM-D) and mood elevation (SUM-ME) subscales of the CMF.
RESULTS: Robust correlations were observed between SUM-D and the formal depression scales, HRSD and MADRS, r = 0.79, r = 0.88. respectively. Similar robust correlations were also found between the SUM-ME and the formal mood elevation scales, YMRS and the MRS, r = 0.84, r = 0.86, respectively.
CONCLUSION: The CMF appears to offer a reasonable alternative to the formal rating scales typically used in research studies.

Entities:  

Mesh:

Year:  2002        PMID: 12479665     DOI: 10.1034/j.1399-5618.2002.01195.x

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN: 1398-5647            Impact factor:   6.744


  51 in total

1.  Testing for clinical inertia in medication treatment of bipolar disorder.

Authors:  Dominic Hodgkin; Elizabeth L Merrick; Peggy L O'Brien; Thomas G McGuire; Sue Lee; Thilo Deckersbach; Andrew A Nierenberg
Journal:  J Affect Disord       Date:  2016-06-21       Impact factor: 4.839

2.  Genome-wide association study of suicide attempts in mood disorder patients.

Authors:  Roy H Perlis; Jie Huang; Shaun Purcell; Maurizio Fava; A John Rush; Patrick F Sullivan; Steven P Hamilton; Francis J McMahon; Thomas G Schulze; Thomas Schulze; James B Potash; Peter P Zandi; Virginia L Willour; Brenda W Penninx; Dorret I Boomsma; Nicole Vogelzangs; Christel M Middeldorp; Marcella Rietschel; Markus Nöthen; Sven Cichon; Hugh Gurling; Nick Bass; Andrew McQuillin; Marian Hamshere; Nick Craddock; Pamela Sklar; Jordan W Smoller
Journal:  Am J Psychiatry       Date:  2010-11-01       Impact factor: 18.112

3.  Identifying clinical net benefit of psychotropic medication use with latent variable techniques: Evidence from Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  Natalie Bareis; Juan Lu; Cynthia K Kirkwood; Susan G Kornstein; Elwin Wu; Briana Mezuk
Journal:  J Affect Disord       Date:  2018-05-29       Impact factor: 4.839

4.  Age at onset, course of illness and response to psychotherapy in bipolar disorder: results from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  A Peters; L G Sylvia; P V da Silva Magalhães; D J Miklowitz; E Frank; M W Otto; N S Hansen; D D Dougherty; M Berk; A A Nierenberg; T Deckersbach
Journal:  Psychol Med       Date:  2014-04-10       Impact factor: 7.723

5.  Systematic Review of Symptom Assessment Measures for Use in Measurement-Based Care of Bipolar Disorders.

Authors:  Joseph M Cerimele; Simon B Goldberg; Christopher J Miller; Stephen W Gabrielson; John C Fortney
Journal:  Psychiatr Serv       Date:  2019-02-05       Impact factor: 3.084

6.  SPECIFIC MOOD SYMPTOMS CONFER RISK FOR SUBSEQUENT SUICIDAL IDEATION IN BIPOLAR DISORDER WITH AND WITHOUT SUICIDE ATTEMPT HISTORY: MULTI-WAVE DATA FROM STEP-BD.

Authors:  Jonathan P Stange; Evan M Kleiman; Louisa G Sylvia; Pedro Vieira da Silva Magalhães; Michael Berk; Andrew A Nierenberg; Thilo Deckersbach
Journal:  Depress Anxiety       Date:  2016-01-12       Impact factor: 6.505

7.  Genetics of psychotropic medication induced side effects in two independent samples of bipolar patients.

Authors:  Chiara Fabbri; Daniel Souery; Raffaella Calati; Concetta Crisafulli; Armando Chierchia; Diego Albani; Gianluigi Forloni; Alberto Chiesa; Rosalba Martines; Othman Sentissi; Julien Mendlewicz; Giovanni De Girolamo; Alessandro Serretti
Journal:  J Neural Transm (Vienna)       Date:  2014-08-17       Impact factor: 3.575

Review 8.  Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring.

Authors:  Kristina M Deligiannidis; Nancy Byatt; Marlene P Freeman
Journal:  J Clin Psychopharmacol       Date:  2014-04       Impact factor: 3.153

9.  Impact of substance use disorders on recovery from episodes of depression in bipolar disorder patients: prospective data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).

Authors:  Michael J Ostacher; Roy H Perlis; Andrew A Nierenberg; Joseph Calabrese; Jonathan P Stange; Ihsan Salloum; Roger D Weiss; Gary S Sachs
Journal:  Am J Psychiatry       Date:  2009-12-15       Impact factor: 18.112

10.  Revisiting the effectiveness of standard antidepressants in bipolar disorder: are monoamine oxidase inhibitors superior?

Authors:  Alan G Mallinger; Ellen Frank; Michael E Thase; Michelle M Barwell; Nancy Diazgranados; David A Luckenbaugh; David J Kupfer
Journal:  Psychopharmacol Bull       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.